Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Treatment of Chronic Lymphocytic Leukemia Patients with Lenalidomide Induces Down-Regulation of miR342-3p Associated with Over-Expression of Tumor Suppressor RASSF4,

Emanuela M. Ghia, PhD, Lillian Werner, Danelle F. James, M.D., Donna Neuberg, ScD, Laura G Corral, Senior, Scientist, Laura Z. Rassenti, Ph.D., Carlo M. Croce, MD, Thomas J. Kipps, M.D., Ph.D

Blood (2011) 118 (21): 3885.

https://doi.org/10.1182/blood.V118.21.3885.3885

Published: 2011

Journal Articles

A Rho-GTPase Effector, Rhotekin-2 (RTKN2) Is Associated with BMP8b and IL-16 Cytokine Expression and Increased Sensitivity to Apoptosis in Lymphocytes.

Fiona M. Collier, BAppSc, Adele J. Baker, BSc, Ken Walder, PhD, Nicole Stupka, PhD, Sheree D. Martin, BScHons, Mark A. Kirkland, MBBS, PhD

Blood (2007) 110 (11): 2293.

https://doi.org/10.1182/blood.V110.11.2293.2293

Published: 2007

Journal Articles

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Cristina N. Boß, Frank Grünebach, PhD, Katharina M. Brauer, Toni Weinschenk, PhD, Lothar Kanz, MD, Stefan Stevanovic, PhD, Hans-Georg Rammensee, PhD, Peter Brossart, MD

Blood (2006) 108 (11): 3703.

https://doi.org/10.1182/blood.V108.11.3703.3703

Published: 2006

Journal Articles

Biochemical and functional characterization of Rab27a mutations occurring in Griscelli syndrome patients

Gaël Ménasché, Jérôme Feldmann, Anne Houdusse, Catherine Desaymard, Alain Fischer, Bruno Goud, Geneviève de Saint Basile

Blood (2003) 101 (7): 2736–2742.

https://doi.org/10.1182/blood-2002-09-2789

Published: 2003

Journal Articles

PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac

Jong Suk Kim, Xiaodong Peng, Pradip K. De, Robert L. Geahlen, Donald L. Durden

Blood (2002) 99 (2): 694–697.

https://doi.org/10.1182/blood.V99.2.694

Published: 2002

NARROW

Treatment of Chronic Lymphocytic Leukemia Patients with Lenalidomide Induces Down-Regulation of miR342-3p Associated with Over-Expression of Tumor Suppressor RASSF4,

A Rho-GTPase Effector, Rhotekin-2 (RTKN2) Is Associated with BMP8b and IL-16 Cytokine Expression and Increased Sensitivity to Apoptosis in Lymphocytes.

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Biochemical and functional characterization of Rab27a mutations occurring in Griscelli syndrome patients

PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac

Email alerts

ASH Publications

American Society of Hematology

Treatment of Chronic Lymphocytic Leukemia Patients with Lenalidomide Induces Down-Regulation of miR342-3p Associated with Over-Expression of Tumor Suppressor RASSF4,

A Rho-GTPase Effector, Rhotekin-2 (RTKN2) Is Associated with BMP8b and IL-16 Cytokine Expression and Increased Sensitivity to Apoptosis in Lymphocytes.

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Biochemical and functional characterization of Rab27a mutations occurring in Griscelli syndrome patients

PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only